IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Bernard Moss Nicholas P. Restifo |
| Publication date | May 1, 1996 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |